Worldwide burden of cancer attributable to HPV by site, country and HPV type
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 141, Issue 4, Pages 664-670
Publisher
Wiley
Online
2017-04-04
DOI
10.1002/ijc.30716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Human Papillomavirus in Penile Carcinomas Worldwide
- (2016) Laia Alemany et al. EUROPEAN UROLOGY
- Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa
- (2016) Gary M. Clifford et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
- (2016) Xavier Castellsagué et al. JNCI-Journal of the National Cancer Institute
- Quality vaccines for all people
- (2016) Sonia Pagliusi et al. VACCINE
- HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
- (2016) Xavier Castellsagué et al. JNCI-Journal of the National Cancer Institute
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Cancers attributable to infections among adults with HIV in the United States
- (2015) Catherine de Martel et al. AIDS
- Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions
- (2015) Beatriz Serrano et al. EUROPEAN JOURNAL OF CANCER
- World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer
- (2015) Nancy Santesso et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
- (2015) Daniel C. Beachler et al. JNCI-Journal of the National Cancer Institute
- Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
- (2015) Aimée R Kreimer et al. LANCET ONCOLOGY
- HPV-FASTER: broadening the scope for prevention of HPV-related cancer
- (2015) F. Xavier Bosch et al. Nature Reviews Clinical Oncology
- Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
- (2015) Daniel C. Beachler et al. JNCI-Journal of the National Cancer Institute
- Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
- (2014) Mark Jit et al. Lancet Global Health
- No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors
- (2013) Michelle M. Rietbergen et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Human papillomavirus and cervical cancer
- (2013) Emma J Crosbie et al. LANCET
- Clinical trials of human papillomavirus vaccines and beyond
- (2013) Matti Lehtinen et al. Nature Reviews Clinical Oncology
- Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
- (2012) Peng Guan et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- HPV-associated head and neck cancer: a virus-related cancer epidemic
- (2010) Shanthi Marur et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started